Dr. Reddy's Laboratories had the highest share trade value in the month of November 2022 of about 57.65 U.S. dollars at the New York Stock Exchange (NYSE). Dr. Reddy's low share value during the month of March 2023 was 52.55 U.S. dollars. Dr. Reddy's is one of the biggest Indian multinational pharmaceutical companies based in the southern city of Hyderabad.
Value of Dr. Reddy's Laboratories Limited's monthly share trade at New York Stock Exchange in financial year 2023 (in U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
8
- Basic Statistic Top drugs based on projected 2023 global sales
- Basic Statistic Share value of the generic pharmaceuticals market in Estonia 2008-2022
- Premium Statistic Leading European pharmaceutical & biotechnology companies by market cap 2023
- Basic Statistic Share value of the generic pharmaceuticals market in Slovakia 2002-2021
- Basic Statistic Value share of generic pharmaceuticals market in Czechia 2011-2021
- Basic Statistic Share value of the generic pharmaceuticals market in Finland 2012-2021
- Premium Statistic Mexico: pharmaceutical production 2017-2022
- Basic Statistic Cardiovascular system pharmaceutical consumption in Belgium 2008-2021
Related statistics
10
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
- Premium Statistic Sun Pharma's income FY 2010-2022
- Premium Statistic Sun Pharma's profit after tax FY 2014-2022
- Premium Statistic Cipla's BSE market price FY 2021-2023
- Premium Statistic Net profit of major pharma companies India 2022
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic Indian pharmaceutical export value FY 2012-2023
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic MAT of therapies in Indian pharma 2022
Further related statistics
10
- Net profit of Midea Group FY 2012-FY 2022
- MorphoSys' revenue 2006-2022
- MorphoSys' research & development expenditure 2006-2022
- Sales of Nestlé in Zone North America (NA) from 2021-2022, by product categories
- Global sales of the Nestlé Group 2005-2022
- Nestlé Group's sales distribution worldwide 2022, by region
- EBIT margin of the Nestlé Group 2009-2022, by product category
- Sales of Nestlé in AOA 2021-2022, by product categories
- Pfizer's ad spending 2008-2022
- Global net earnings of the Brunswick Corporation 2007-2022
Further Content: You might find this interesting as well
Statistics
- Net profit of Midea Group FY 2012-FY 2022
- MorphoSys' revenue 2006-2022
- MorphoSys' research & development expenditure 2006-2022
- Sales of Nestlé in Zone North America (NA) from 2021-2022, by product categories
- Global sales of the Nestlé Group 2005-2022
- Nestlé Group's sales distribution worldwide 2022, by region
- EBIT margin of the Nestlé Group 2009-2022, by product category
- Sales of Nestlé in AOA 2021-2022, by product categories
- Pfizer's ad spending 2008-2022
- Global net earnings of the Brunswick Corporation 2007-2022
Dr. Reddy's Laboratories. (July 1, 2023). Value of Dr. Reddy's Laboratories Limited's monthly share trade at New York Stock Exchange in financial year 2023 (in U.S. dollars) [Graph]. In Statista. Retrieved September 30, 2023, from https://www.statista.com/statistics/991405/india-drreddy-s-laboratories-monthly-traded-shares-value-nyse/
Dr. Reddy's Laboratories. "Value of Dr. Reddy's Laboratories Limited's monthly share trade at New York Stock Exchange in financial year 2023 (in U.S. dollars)." Chart. July 1, 2023. Statista. Accessed September 30, 2023. https://www.statista.com/statistics/991405/india-drreddy-s-laboratories-monthly-traded-shares-value-nyse/
Dr. Reddy's Laboratories. (2023). Value of Dr. Reddy's Laboratories Limited's monthly share trade at New York Stock Exchange in financial year 2023 (in U.S. dollars). Statista. Statista Inc.. Accessed: September 30, 2023. https://www.statista.com/statistics/991405/india-drreddy-s-laboratories-monthly-traded-shares-value-nyse/
Dr. Reddy's Laboratories. "Value of Dr. Reddy's Laboratories Limited's Monthly Share Trade at New York Stock Exchange in Financial Year 2023 (in U.S. Dollars)." Statista, Statista Inc., 1 Jul 2023, https://www.statista.com/statistics/991405/india-drreddy-s-laboratories-monthly-traded-shares-value-nyse/
Dr. Reddy's Laboratories, Value of Dr. Reddy's Laboratories Limited's monthly share trade at New York Stock Exchange in financial year 2023 (in U.S. dollars) Statista, https://www.statista.com/statistics/991405/india-drreddy-s-laboratories-monthly-traded-shares-value-nyse/ (last visited September 30, 2023)
Value of Dr. Reddy's Laboratories Limited's monthly share trade at New York Stock Exchange in financial year 2023 (in U.S. dollars) [Graph], Dr. Reddy's Laboratories, July 1, 2023. [Online]. Available: https://www.statista.com/statistics/991405/india-drreddy-s-laboratories-monthly-traded-shares-value-nyse/